Correlation between CD11b expression quantified by flow cytometry in PB samples from patients with ALL at diagnosis and response to induction therapy
| . | No. of patients . | Spearman coefficient . | P . |
|---|---|---|---|
| BRR | |||
| Day 8 | 107 | −0.27 | .005 |
| Day 15 | 69 | −0.26 | .030 |
| Day 33 | 71 | −0.25 | .036 |
| Percentage of blasts | |||
| Day 8 | 107 | 0.32 | .001 |
| Day 15 | 78 | 0.22 | .053 |
| Day 33 | 77 | 0.28 | .014 |
| . | No. of patients . | Spearman coefficient . | P . |
|---|---|---|---|
| BRR | |||
| Day 8 | 107 | −0.27 | .005 |
| Day 15 | 69 | −0.26 | .030 |
| Day 33 | 71 | −0.25 | .036 |
| Percentage of blasts | |||
| Day 8 | 107 | 0.32 | .001 |
| Day 15 | 78 | 0.22 | .053 |
| Day 33 | 77 | 0.28 | .014 |
PB indicates peripheral blood; ALL, acute lymphoblastic leukemia; and BRR, blast reduction rate.